Growing investment in personalized medicine is fueling the need for high-quality plasmid DNA. Biopharmaceutical companies are expanding manufacturing capabilities to support clinical and commercial supply. The market is becoming a critical foundation for next-generation therapeutic development. DNA Plasmid Manufacturing Market to Hit US$ 2.65B by 2031 Boom The DNA plasmid manufacturing market...

The global Healthcare Contract Manufacturing Organization Market is witnessing strong expansion, driven by increasing outsourcing trends across pharmaceutical and biotechnology companies. According to industry analysis, the market is projected to grow at a CAGR of 9.6% from 2025 to 2031, reflecting steady demand for specialized manufacturing services. Healthcare companies are increasingly...